Furthermore, we summarize novel approaches of engaging the CRISPR/Cas9 system in establishing an adequate model of neurodegenerative disease and in the treatment of SOD1-linked forms of ALS. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.